SynthesisClinical drug investigation2016

Tumour Risk with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus Patients: A Systematic Review.

Xia Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.